Jenoptik (JEN) PT Set at €33.50 by Warburg Research

Share on StockTwits

Warburg Research set a €33.50 ($38.95) price objective on Jenoptik (ETR:JEN) in a report issued on Thursday morning. The brokerage currently has a neutral rating on the stock.

Several other brokerages have also commented on JEN. Baader Bank set a €30.00 ($34.88) price target on Jenoptik and gave the company a neutral rating in a research note on Monday, March 11th. Hauck & Aufhaeuser set a €32.50 ($37.79) price target on Jenoptik and gave the company a buy rating in a research note on Wednesday, February 13th. Independent Research set a €25.00 ($29.07) price target on Jenoptik and gave the company a sell rating in a research note on Thursday, February 14th. HSBC set a €30.00 ($34.88) price target on Jenoptik and gave the company a neutral rating in a research note on Thursday, February 14th. Finally, Kepler Capital Markets set a €34.50 ($40.12) price target on Jenoptik and gave the company a neutral rating in a research note on Wednesday, February 13th. One equities research analyst has rated the stock with a sell rating and seven have issued a hold rating to the stock. The stock presently has an average rating of Hold and an average target price of €31.21 ($36.30).

Shares of Jenoptik stock opened at €32.90 ($38.26) on Thursday. Jenoptik has a 52 week low of €22.02 ($25.60) and a 52 week high of €39.54 ($45.98). The firm has a market capitalization of $1.88 billion and a PE ratio of 22.88. The company has a current ratio of 2.18, a quick ratio of 1.22 and a debt-to-equity ratio of 23.51.

Jenoptik Company Profile

Jenoptik AG operates as an integrated photonics company in Germany and internationally. The company's Opticals & Life Science division develops and manufactures micro-optics for beam shaping for use in the semiconductor industry, as well as for laser material processing; and optical systems and components for information and communication, security, and defense technologies.

Further Reading: How a Strangle Strategy is different from a Straddle Strategy

Analyst Recommendations for Jenoptik (ETR:JEN)

Receive News & Ratings for Jenoptik Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jenoptik and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Albireo Pharma Inc  Expected to Announce Earnings of -$1.44 Per Share
Albireo Pharma Inc Expected to Announce Earnings of -$1.44 Per Share
Dynex Capital Inc  Plans Monthly Dividend of $0.18
Dynex Capital Inc Plans Monthly Dividend of $0.18
Insider Buying: Ipsidy Inc  CFO Acquires $25,000.00 in Stock
Insider Buying: Ipsidy Inc CFO Acquires $25,000.00 in Stock
Kenneth Michael Dedeluk Sells 5,000 Shares of Computer Modelling Group Ltd.  Stock
Kenneth Michael Dedeluk Sells 5,000 Shares of Computer Modelling Group Ltd. Stock
Tabula Rasa HealthCare Inc  Director Sells $51,520.00 in Stock
Tabula Rasa HealthCare Inc Director Sells $51,520.00 in Stock
Insider Buying: Immunomedics, Inc.  Insider Purchases $66,750.00 in Stock
Insider Buying: Immunomedics, Inc. Insider Purchases $66,750.00 in Stock


 
© 2006-2019 Zolmax.